5 FAQs About Immunotherapy for Renal Cell Carcinoma


Jennifer L.W. Fink RN, BSN

Was this helpful? (21)

Kidney cancer is one of the 10 most common cancers in both men and women–and the most common type of kidney cancer is called renal cell carcinoma. If caught and treated early, the prognosis is good. But until recently, doctors had few good options to offer patients whose cancer spread despite treatment.

All that is changing. In recent years, a new class of immunotherapy drugs, “checkpoint inhibitors,” was approved to treat certain types of skin and lung cancer. Since then, those drugs have shown promise fighting a lot of different cancers, including renal cell carcinoma.

What is immunotherapy, and how can it fight cancer? These experts explain this exciting new treatment.

2018 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.